Calculated NOK return from USD · USD (Accumulation (NOK Calculated)
Computed from NAV history (total return, NOK, to 13 Nov 2026)
Last NAV 11,18 USD · 13 Nov 2026
Returns by period · NOK · net
ann. 3Y+
+17,9 %
YTD
+22,0 %
1y
+15,1 %
3y, annualised
+4,3 %
5y, annualised
Fund size
1,6 mrd. USD
Total fund AUM
Ongoing charge
0,40 %
Annual · class USD (Accumulation
Performance fee
None
Stated by the manager
SFDR
Article 8
Sustainability
Launched
Sept 2016
ISIN IE00BYZK4776
BenchmarkSTOXX Global Breakthrough Health Care · Net
Risk
Volatility (stated by the manager)15,4 %
Beta1,00
About the fund
The fund
BlackRock iShares Healthcare Innovation UCITS ETF is an exchange-traded index fund with history back to 2016. It is offered by BlackRock, the world's largest asset manager, which owns the iShares ETF brand. BlackRock is headquartered in New York and is publicly listed with dispersed ownership.
Investment philosophy
The fund tracks the STOXX Global Breakthrough Healthcare index. The index consists of companies in developed and emerging markets that earn significant revenues from areas pushing the boundaries of medical treatment and technology.
The managers
The fund tracks an index, so its composition is set by the index rules and not by the choices of named portfolio managers.
The portfolio
The portfolio is broad, with many more positions than comparable funds, and the largest positions make up a relatively small share of the weight. Alongside health care, the fund has a lasting weighting towards information technology. Companies such as Natera, Genmab, Illumina and Guardant Health recur among the larger positions.
FundTelligence description · 18/10/2026
Start date not confirmed — not ranked
Portfolio managers
Managed by a team: BlackRock Asset Management Ireland Limited
Fund data is taken from the managers’ own reports, otherwise computed from NAV history and, as a last resort, taken from distributor listings. Not official figures; verify with the fund provider before investing.